Evidence map›Paper›PMID 31596369›Full record

Trial reportJournal of applied oral science : revista FOB2019

A randomized, prospective clinical study evaluating effectiveness of a bulk-fill composite resin, a conventional composite resin and a reinforced glass ionomer in Class II cavities: one-year results.

Hacer Balkaya, Soley Arslan, Kanşad Pala

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of applied oral science : revista FOB, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05276154 (Clinical Performance of Thermo-Viscous Bulk-Fill Resin Composite Restorations in Comparison to Conventional Bulk-Fill Resin Composite Restorations in Posterior Teeth A Randomized Control Clinical Trial), which is not on this map. Cited by 37 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05276154 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Clinical Performance of Thermo-Viscous Bulk-Fill Resin Composite Restorations in Comparison to Conventional Bulk-Fill Resin Composite Restorations in Posterior Teeth A Randomized Control Clinical Trial

TypeinterventionalSponsorMinia UniversityRan2022 to 2023Enrolled32ConditionsCaries,DentalArmsthermoviscous bulkfill composite (Viscalor)
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Clinical Performance of Glass Ionomer Cement in Load-Bearing Restorations: A Systematic Review.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Two-Year Survival of High-Viscosity Glass Ionomer in Children with Molar Incisor Hypomineralization.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2021
    Trial
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hacer BalkayaErciyes University, Faculty of Dentistry, Department of Restorative Dentistry, Kayseri, Turkey.ORCID http://orcid.org/0000-0001-9180-5610
Soley ArslanErciyes University, Faculty of Dentistry, Department of Restorative Dentistry, Kayseri, Turkey.
Kanşad PalaErciyes University, Faculty of Dentistry, Department of Restorative Dentistry, Kayseri, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesBulk-fill restorative materials such as bulk-fill composite resins and high viscous glass ionomer cements have become very popular materials in operative dentistry because their application is easy and time-saving. The aim of this clinical study was to evaluate the clinical performance of a highly viscous reinforced glass ionomer material, a bulk-fill composite resin and a micro hybrid composite resin in Class II restorations. METHODOLOGY: In total, 109 Class II restorations were performed in 54 patients using three different restorative materials: Charisma Smart Composite (CSC); Filtek Bulk Fill Posterior Restorative (FBF); Equia Forte Fil (EF). Single Bond Universal adhesive (3M ESPE, Germany) was used with composite resin restorations. The restorations were evaluated using modified USPHS criteria in terms of retention, color match, marginal discoloration, anatomic form, contact point, marginal adaptation, secondary caries, postoperative sensitivity and surface texture. The data were analyzed using Chi-Square, Fischer's and McNemar's tests.

resultsAt the end of one year, 103 restorations were followed up. No changes were observed during the first 6 months. At the end of one year, there were small changes in composite restorations (FBF and CSC) but no statistically significant difference was observed between the clinical performances of these materials for all criteria (p>0.05). However, there was a statistically significant difference between EF, FBF and CSC groups in all parameters except marginal discoloration, secondary caries and postoperative sensitivity in one-year evaluation (p<0.05).

conclusionBulk-fill composite resins and conventional composite resins showed more successful clinical performance than highly viscous reinforced glass ionomers in Class II cavities.

Indexed as

AdultBisphenol A-Glycidyl MethacrylateComposite ResinsDental CariesDental Marginal AdaptationDental Restoration, PermanentFemaleGlass Ionomer CementsHumansMaleProspective StudiesReproducibility of ResultsSex DistributionTreatment OutcomeYoung AdultBisphenol A-Glycidyl MethacrylateCharisma composite resinComposite ResinsEQUIA compositeFiltek Bulk FillGlass Ionomer Cementssingle bond

Identifiers

PMID31596369
PMCPMC6768121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.